Stay updated on Empagliflozin Effects on Cardiac Remodeling in Non-Diabetics Clinical Trial
Sign up to get notified when there's something new on the Empagliflozin Effects on Cardiac Remodeling in Non-Diabetics Clinical Trial page.

Latest updates to the Empagliflozin Effects on Cardiac Remodeling in Non-Diabetics Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe study record history now includes Revision v3.5.2 and removes Revision v3.5.0.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check38 days agoChange DetectedRevision v3.5.0 was added and revision v3.4.3 was removed from the Record History.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision v3.4.3 was added and revision v3.4.2 was removed from the study record history.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision: v3.4.2 added, and the prior site-wide funding/operating-status notice (v3.4.1) was removed. The update does not modify core study data, eligibility criteria, or results.SummaryDifference0.9%

- Check81 days agoChange DetectedAdded a government funding notice about open status of the NIH Clinical Center and updated the record version to v3.4.1; removed the previous v3.4.0 entry.SummaryDifference0.9%

- Check88 days agoChange DetectedUI updates on the Record History page include a glossary toggle, green/red color-coding of changes, and a new revision label (v3.4.0); older label and data references (No FEAR Act data, Revision: v3.3.4) were removed.SummaryDifference1%

Stay in the know with updates to Empagliflozin Effects on Cardiac Remodeling in Non-Diabetics Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Empagliflozin Effects on Cardiac Remodeling in Non-Diabetics Clinical Trial page.